Resource Center

More information?
More information?
Leave blank for all
Leave blank for all
To see all resources, click Reset
931 RESULTS FOUND
AdvaMed 2016-2017 Womens Executive Network Leadership Circle Bios
August 14, 2017 | Fact Sheet
It's Time to Protect Innovation (Ad)
August 11, 2017 | Fact Sheet
AdvaMed Statement of Record to Senate Finance
August 11, 2017 | Statement
Alert: CMS Releases Final Rule on the FY 2018 Inpatient Prospective Payment System
August 2, 2017 | Guidance
AdvaMed Comments Regarding the Administration’s Reviews and Report to the President on Trade Agreement Violations and Abuses
July 31, 2017 | Comments
AdvaMed Comments Regarding Causes of Significant Trade Deficits for 2016
July 31, 2017 | Comments
AdvaMed Proposals for NAFTA Renegotiation
July 31, 2017 | Statement
AdvaMed Comments on Docket Number FDA-2015-N-2002 Intended Uses
July 18, 2017 | Comments
Medical Device Tax Ads - July 18, 2017
July 18, 2017 | Fact Sheet
NAM Manufacturing Compliance Institute Flyer
July 12, 2017 | Administrative
FDARA Section-by-Section
July 11, 2017 |
NAM Manufacturers’ Compliance Institute
July 11, 2017 | Fact Sheet
Weekly AdvaMed Accel Policy Update (T & R) - July 11, 2017
July 11, 2017 | Agenda
FDARA 2017 H.R. 2430
July 11, 2017 |
AdvaMed Comments on Docket Number FDA-2017-N-1067 ASCA Program
June 30, 2017 | Comments
Press release: Amicus Brief Filed with U.S. Supreme Court in Ethicon v. Huskey
June 26, 2017 | Statement
AdvaMed Files Amicus Brief with U.S. Supreme Court (Ethicon v. Huskey)
June 23, 2017 | Testimony
Weekly AdvaMed Accel Policy Update (Global) - June, 20 2017
June 19, 2017 | Agenda
Downtown DC Hotels
June 12, 2017 | Administrative
Weekly AdvaMed Accel Policy Update (T&R) - June 6, 2017
June 6, 2017 | Agenda
AdvaMed Comments on Health Canada Public Release of Clinical Information
May 25, 2017 | Comments
AdvaMed Comments on Docket No. FDA-2017-D-0040; Draft Guidance for Industry: How to Prepare a Pre- Request for Designation (Pre-RFD)
May 24, 2017 | Comments
AdvaMed Comments on Docket Number FDA-2017-N-0041 Agency Info Collection Activities
May 15, 2017 | Comments
AdvaMed Comments on FDA-2017-N-1129 Class II Exemptions
May 15, 2017 | Comments
Understanding Evidence about the Value of Medical Technologies
May 12, 2017 | Summary

Pages